logo
episode-header-image
May 21
20m 12s

Ozempic Is a Hit. So Why Is the Drugmake...

THE WALL STREET JOURNAL & GIMLET
About this episode
Blockbuster drugs. Rising profits. Strong sales. And yet, Novo Nordisk, the Danish company behind the GLP-1 drugs Ozempic and Wegovy, made a surprising move last week: It pushed out its CEO. WSJ's Peter Loftus charts the rise of Ozempic and the fall of CEO Lars Jorgensen. Jessica Mendoza hosts.  Further Listening: Trillion Dollar Shot  Why WeightWatche ... Show More
Up next
Jul 14
Why Elon Musk’s AI Chatbot Went Rogue
Last week, Grok went rogue. The AI chatbot – which users can interact with on X – posted antisemitic comments and graphic descriptions of violence before being deactivated, leaving users with a question: Where were Grok’s guardrails? WSJ’s Alexander Saeedy breaks down what happen ... Show More
22m 52s
Jul 11
Can Superman Save Warner?
The man of steel is back in a new $225 million reboot. Riding on this weekend’s release is the hope that DC Studios will finally begin to match the past successes of its archrival Marvel. Its parent company Warner Bros. Discovery views DC Studios as critical to its success or fai ... Show More
22m 36s
Jul 10
Who Will Be the Next Fed Chair? Maybe Kevin
For years, President Trump has feuded with the Federal Reserve and Chair Jerome Powell over interest rates. And now, two Republicans named Kevin (Kevin Hassett, one of Trump’s closest economic advisers and Kevin Warsh—a former Fed governor) are vying to be the next chairman of th ... Show More
22m 47s
Recommended Episodes
Apr 2025
What’s News in Markets: Lilly Surges, UnitedHealth Plummets, Netflix Aims for $1 Trillion
Why did news from a weight-loss drug pill trial boost Eli Lilly? And how are costs in the Medicare business affecting UnitedHealth? Plus, what ambitious goals has Netflix set for itself? Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove ... Show More
5m 13s
Oct 2024
U.S. Stocks End the Week Higher
Plus: Netflix shares hit a record high following its most profitable quarter ever. And CVS Health fell after the healthcare giant replaced its CEO and warned on earnings. Plus, french fry producer Lamb Weston’s shares soar. Danny Lewis hosts. Sign up for the WSJ's free What's New ... Show More
2m 45s
Oct 2024
What’s News in Markets: United Soars, CVS Warns, Netflix Shines
How did rivals help United take off? And what has investors worried about the health of CVS? Plus, why Netflix shares jumped. Host Francesca Fontana discusses the biggest stock moves of the week and the news that drove them. Sign up for the WSJ's free Markets A.M. newsletter. Lea ... Show More
5m 27s
Jul 2024
Dow Falls More Than 500 Points
Plus: Shares of Eli Lilly and Novo Nordisk decline as competition in the anti-obesity drug market ramps up. After the bell, Netflix reported stronger revenue, but said subscriber growth in the current quarter will be weaker than a year ago. J.R. Whalen reports. Sign up for the WS ... Show More
2m 37s
Jul 22
Why are Consumer Co CEOs Losing Their Jobs?
It’s been a turbulent fortnight for corporate leadership, with sudden CEO exits at companies like HUL, Coca Cola bottler HCCB, L’Oréal, Diageo, Kenvue and WPP. In this episode of The Morning Brief, host Ratna Bhushan speaks to ET’s Associate Editor Arijit Barman and Vibhav Dhawan ... Show More
26m 53s
Sep 2024
Nike CEO Abruptly Steps Down After Struggling Sales & 23andMe in Turmoil
Episode 414: Neal and Toby break down with Nike CEO John Donahoe announces he is retiring after the company's struggling sales. Plus, the guys explain why every single board member resigned from 23andMe this week. Then, Olive Garden cuts a deal with Uber to deliver bread sticks a ... Show More
30m 31s
Apr 2025
SOTS 2nd Hour: Tariff Updates, Earnings Wrap-up, and Is This Rally Real? – plus: Coca-Cola CEO Talks Results 4/29/25
Fresh news on the tariff front when it comes to potential deals – and hopes of relief for the automakers… Carl Quintanilla, Sara Eisen, and David Faber broke down the latest from the White House, alongside the morning’s biggest earnings stories: from GM pulling guidance and delay ... Show More
42m 32s
Nov 2024
What’s News in Markets: Tesla Seesaw, Pharma Selloff, Streaming Shines
How has Elon Musk’s deepening relationship with President-elect Donald Trump affected Tesla stock? And why did Big Pharma stocks sell off? Plus, what did Disney and Spotify have to say about trends in streaming? Host Francesca Fontana discusses the biggest stock moves of the week ... Show More
5m 48s
Sep 2024
Making Sense of Nvidia’s Record Drop
A.M. Edition for Sep. 4. WSJ finance editor Alex Frangos tells us where investors are looking for clues on where the U.S. economy is headed and discusses Nvidia’s outsize influence on markets after yesterday’s selloff. Plus, the killing of an American-Israeli hostage in Gaza brin ... Show More
13m 32s